Bokus

Napoleone Ferrara – författare

Visar alla böcker från författaren Napoleone Ferrara. Handla med fri frakt och snabb leverans.

4 produkter

  1. Napoleone Ferrara - Angiogenesis, Häftad. Tillgänglighet: Lägg i varukorg

    Angiogenesis

    From Basic Science to Clinical Applications

    Av Napoleone Ferrara

    Häftad, 2019

    1071 kr

    Lägg i varukorg

    Why a new book on angiogenesis and why now? For the first time concepts proposed over 30 years ago have found clinical validation. In the last two years the first antiangiogenic agents have been approved by the FDA for the treatment of cancer and age-related macular degeneration. Not surprisingly, …

  2. Napoleone Ferrara - Angiogenesis, E-bok. Tillgänglighet: Lägg i varukorg

    Angiogenesis

    From Basic Science to Clinical Applications

    Av Napoleone Ferrara

    E-bok, 2006

    1239 kr

    Lägg i varukorg

    Why a new book on angiogenesis and why now? For the first time concepts proposed over 30 years ago have found clinical validation. In the last two years the first antiangiogenic agents have been approved by the FDA for the treatment of cancer and age-related macular degeneration. Not surprisingly, …

  3. Napoleone Ferrara - Angiogenesis, E-bok. Tillgänglighet: Lägg i varukorg

    Angiogenesis

    From Basic Science to Clinical Applications

    Av Napoleone Ferrara

    E-bok, 2006

    1266 kr

    Lägg i varukorg

    Why a new book on angiogenesis and why now? For the first time concepts proposed over 30 years ago have found clinical validation. In the last two years the first antiangiogenic agents have been approved by the FDA for the treatment of cancer and age-related macular degeneration. Not surprisingly, …

  4. Napoleone Ferrara - Angiogenesis, Inbunden. Tillgänglighet: Tillfälligt slut

    Angiogenesis

    From Basic Science to Clinical Applications

    Av Napoleone Ferrara

    Inbunden, 2006

    2386 kr

    Tillfälligt slut

    Why a new book on angiogenesis and why now? For the first time concepts proposed over 30 years ago have found clinical validation. In the last two years the first antiangiogenic agents have been approved by the FDA for the treatment of cancer and age-related macular degeneration. Not surprisingly, …